References
AL-BILTAGI, M. A. M., ABO-ELEZZ, A., ABD-ELHAFEZ, M. A., MABROUK, M. M.
& SULIMAN, G. A. 2017. Beneficial Effects of Omega-3 Supplement to the
Enteral Feeding in Children With Mild to Moderate Sepsis. Journal
of Intensive Care Medicine, 32, 212-217.
BORENSTEIN, M., HEDGES, L. V., HIGGINS, J. P. & ROTHSTEIN, H. R. 2010.
A basic introduction to fixed‐effect and random‐effects models for
meta‐analysis. Research synthesis methods, 1, 97-111.
CALDER, P. C. 2006. n-3 polyunsaturated fatty acids, inflammation, and
inflammatory diseases. Am J Clin Nutr, 83, 1505s-1519s.
CARCILLO, J. A., PODD, B., ANEJA, R., WEISS, S. L., HALL, M. W.,
CORNELL, T. T., SHANLEY, T. P., DOUGHTY, L. A. & NGUYEN, T. C. 2017.
Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.Pediatr Crit Care Med, 18, S32-s45.
CARR, A. C. & MAGGINI, S. 2017. Vitamin C and Immune Function.Nutrients, 9.
CHEN, Y., ZHOU, Z. Q., YANG, H. H. & LU, H. G. 2017. Effect of omega-3
fatty acids on acute lung injury and acute respiratory distress
syndrome: a systematic review and meta-analysis. International
Journal of Clinical and Experimental Medicine, 10,15920-15926.
COHEN, D. A., BYHAM-GRAY, L. & DENMARK, R. M. 2013. Impact of two
pulmonary enteral formulations on nutritional indices and outcomes.J Hum Nutr Diet, 26, 286-293.
COVAR, R., GLEASON, M., MACOMBER, B., STEWART, L., SZEFLER, P.,
ENGELHARDT, K., MURPHY, J., LIU, A., WOOD, S., DEMICHELE, S., GELFAND,
E. W. & SZEFLER, S. J. 2010. Impact of a novel nutritional formula on
asthma control and biomarkers of allergic airway inflammation in
children. Clin. Exp. Allergy, 40, 1163-1174.
DAS, U. N. 2013. n-3 fatty acids, gamma-linolenic acid, and antioxidants
in sepsis. Crit Care, 17.
DERSIMONIAN, R. & LAIRD, N. 1986. Meta-analysis in clinical trials.Controlled clinical trials, 7, 177-188.
ELAMIN, E. M., HUGHES, L. F. & DREW, D. 2005. Effect of enteral
nutrition with eicosapentaenoic acid (EPA), gamma-linoleic acid (GLA),
and antioxidants reduces alveolar inflammation mediators and protein
influx in patients with acute respiratory distress syndrome (ARDS).Chest, 128, 225S-225S.
ELAMIN, E. M., MILLER, A. C. & ZIAD, S. 2012. Immune Enteral Nutrition
Can Improve Outcomes in Medical-Surgical Patients with ARDS: A
Prospective Randomized Controlled Trial. J Nutr Disord Ther,2, 109.
GADEK, J. E., DEMICHELE, S., KARLSTAD, M., MURRAY, M., PACHT, E.,
DONAHOE, M., ALBERTSON, T., VAN HOOZEN, C., WENNBERG, A., NELSON, J. &
NOURSALEHI, M. 1998. Enteral nutrition with eicosapentaenoic acid (EPA),
γ-linolenic acid (GLA) and antioxidants reduces pulmonary inflammation
and new organ failures in patients with Acute Respiratory Distress
Syndrome (ARDS). Chest, 114.
GADEK, J. E., DEMICHELE, S. J., KARLSTAD, M. D., PACHT, E. R., DONAHOE,
M., ALBERTSON, T. E., VAN HOOZEN, C., WENNBERG, A. K., NELSON, J. L. &
NOURSALEHI, M. 1999. Effect of enteral feeding with eicosapentaenoic
acid, gamma-linolenic acid, and antioxidants in patients with acute
respiratory distress syndrome. Enteral Nutrition in ARDS Study Group.Crit Care Med, 27, 1409-20.
GRAU-CARMONA, T., MORAN-GARCIA, V., GARCIA-DE-LORENZO, A.,
HERAS-DE-LA-CALLE, G., QUESADA-BELLVER, B., LOPEZ-MARTINEZ, J.,
GONZALEZ-FERNANDEZ, C., MONTEJO-GONZALEZ, J. C., BLESA-MALPICA, A.,
ALBERT-BONAMUSA, I., BONET-SARIS, A., HERRERO-MESEGUER, J. I., MESEJO,
A. & ACOSTA, J. 2011. Effect of an enteral diet enriched with
eicosapentaenoic acid, gamma-linolenic acid and anti-oxidants on the
outcome of mechanically ventilated, critically ill, septic patients.Clin Nutr, 30, 578-84.
HAMILTON, L. A. & TROBAUGH, K. A. 2011. Acute Respiratory Distress
Syndrome: Use of Specialized Nutrients in Pediatric Patients and
Infants. Nutrition in Clinical Practice, 26, 26-30.
HEGAZI, R. A. & WISCHMEYER, P. E. 2011. Clinical review: optimizing
enteral nutrition for critically ill patients - a simple data-driven
formula. Crit Care, 15.
HIGGINS, J., DEEKS, J. & ALTMAN, D. 2011. Special topics in statistics:
intention-to-treat issues In: Higgins JPT, Green S, eds. Cochrane
handbook for systematic reviews of interventions (version 5.1. 0).
Cochrane Collaboration .
HIGGINS, J. P. & ALTMAN, D. G. 2008. Assessing risk of bias in included
studies. Cochrane handbook for systematic reviews of
interventions: Cochrane book series , 187-241.
HIGGINS, J. P. & THOMPSON, S. G. 2002. Quantifying heterogeneity in a
meta‐analysis. Statistics in medicine, 21, 1539-1558.
JACOBS, B. R., NADKARNI, V., GOLDSTEIN, B., CHECCHIA, P., AYAD, O.,
BEAN, J. & DEMICHELE, S. 2013. Nutritional immunomodulation in
critically ill children with acute lung injury: Feasibility and impact
on circulating biomarkers. Pediatric Critical Care Medicine,14, e45-e56.
KAGAN, I., COHEN, J., STEIN, M., BENDAVID, I., PINSKER, D., SILVA, V.,
THEILLA, M., ANBAR, R., LEV, S., GRINEV, M. & SINGER, P. 2015.
Preemptive enteral nutrition enriched with eicosapentaenoic acid,
gamma-linolenic acid and antioxidants in severe multiple trauma: a
prospective, randomized, double-blind study. Intensive Care Med,41, 460-469.
KALANTAR-ZADEH, K., BRAGLIA, A., CHOW, J., KWON, O., KUWAE, N., COLMAN,
S., COCKRAM, D. B. & KOPPLE, J. D. 2005. An anti-inflammatory and
antioxidant nutritional supplement for hypoalbuminemic hemodialysis
patients: A pilot/feasibility study. J Ren Nutr, 15,318-331.
LEMOINE, S. C., BRIGHAM, E. P., WOO, H., HANSON, C. K., MCCORMACK, M.
C., KOCH, A., PUTCHA, N. & HANSEL, N. N. 2019. Omega-3 fatty acid
intake and prevalent respiratory symptoms among U.S. adults with COPD.BMC Pulm Med, 19, 97.
LEV, S. & SINGER, P. 2012. n- 3 fatty acids and γ- linolenic acid
supplementation in the nutritional support of ventilated patients with
acute lung injury or acute respiratory distress syndrome.